Moosa Mohammadi - Publications

Affiliations: 
New York University, New York, NY, United States 
Area:
Biochemistry

88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Tassi E, Garman KA, Schmidt MO, Ma X, Kabbara KW, Uren A, Tomita Y, Goetz R, Mohammadi M, Wilcox CS, Riegel AT, Carlstrom M, Wellstein A. Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Scientific Reports. 8: 15973. PMID 30374109 DOI: 10.1038/s41598-018-34238-5  0.56
2018 Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe LM, Mohammadi M, Rivella S, Sitara D. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201700667R. PMID 29481308 DOI: 10.1096/fj.201700667R  0.56
2018 Chen G, Liu Y, Goetz R, Fu L, Jayaraman S, Hu MC, Moe OW, Liang G, Li X, Mohammadi M. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature. PMID 29342138 DOI: 10.1038/nature25451  0.56
2017 Huang C, Liu Y, Beenken A, Jiang L, Gao X, Huang Z, Hsu A, Gross GJ, Wang YG, Mohammadi M, Schultz JEJ. A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration. Cardiovascular Research. PMID 29016740 DOI: 10.1093/cvr/cvx165  0.84
2017 Huang Z, Tan Y, Gu J, Liu Y, Song L, Niu J, Zhao L, Srinivasan L, Lin Q, Deng J, Li Y, Conklin DJ, Neubert TA, Cai L, Li X, ... Mohammadi M, et al. Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Reports. 20: 1717-1728. PMID 28813681 DOI: 10.1016/j.celrep.2017.06.063  0.4
2017 Liu Y, Ma J, Beenken A, Srinivasan L, Eliseenkova AV, Mohammadi M. Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization. Structure (London, England : 1993). PMID 28757146 DOI: 10.1016/j.str.2017.06.016  0.84
2016 Liu Y, Zhao C, Xiao J, Liu L, Zhang M, Wang C, Wu G, Zheng MH, Xu LM, Chen YP, Mohammadi M, Chen SY, Cave M, McClain C, Li X, et al. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury. Scientific Reports. 6: 31026. PMID 27498701 DOI: 10.1038/srep31026  0.84
2015 Huang Z, Marsiglia WM, Basu Roy U, Rahimi N, Ilghari D, Wang H, Chen H, Gai W, Blais S, Neubert TA, Mansukhani A, Traaseth NJ, Li X, Mohammadi M. Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ. Molecular Cell. PMID 26687682 DOI: 10.1016/j.molcel.2015.11.010  0.84
2015 Zhao C, Liu Y, Xiao J, Liu L, Chen S, Mohammadi M, McClain CJ, Li X, Feng W. FGF21 Mediates Alcohol-Induced Adipose Tissue Lipolysis by Activation of Systemic Release of Catecholamine in Mice. Journal of Lipid Research. PMID 26092866 DOI: 10.1194/jlr.M058610  0.84
2015 Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, ... ... Mohammadi M, et al. Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 520: 388. PMID 25739500 DOI: 10.1038/nature14304  0.84
2015 Barker SL, Pastor J, Carranza D, Quiñones H, Griffith C, Goetz R, Mohammadi M, Ye J, Zhang J, Hu MC, Kuro-o M, Moe OW, Sidhu SS. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 223-33. PMID 25324355 DOI: 10.1093/ndt/gfu291  0.84
2015 Huang Z, Tan L, Wang H, Liu Y, Blais S, Deng J, Neubert TA, Gray NS, Li X, Mohammadi M. DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors. Acs Chemical Biology. 10: 299-309. PMID 25317566 DOI: 10.1021/cb500674s  0.84
2014 Villanueva C, Jacobson-Dickman E, Xu C, Manouvrier S, Dwyer AA, Sykiotis GP, Beenken A, Liu Y, Tommiska J, Hu Y, Tiosano D, Gerard M, Leger J, Drouin-Garraud V, Lefebvre H, ... ... Mohammadi M, et al. Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25394172 DOI: 10.1038/gim.2014.166  0.84
2014 Tan L, Wang J, Tanizaki J, Huang Z, Aref AR, Rusan M, Zhu SJ, Zhang Y, Ercan D, Liao RG, Capelletti M, Zhou W, Hur W, Kim N, Sim T, ... ... Mohammadi M, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 111: E4869-77. PMID 25349422 DOI: 10.1073/pnas.1403438111  0.84
2014 Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, ... ... Mohammadi M, et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 513: 436-9. PMID 25043058 DOI: 10.1038/nature13540  0.84
2014 Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, Mohammadi M, Potthoff MJ. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 63: 4057-63. PMID 25008183 DOI: 10.2337/db14-0595  0.84
2014 Fan J, Shan C, Kang HB, Elf S, Xie J, Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, Mohammadi M, Britton LM, Garcia BA, Alečković M, Kang Y, et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Molecular Cell. 53: 534-48. PMID 24486017 DOI: 10.1016/j.molcel.2013.12.026  0.84
2014 Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, Shalhoub V, Mohammadi M, Pohl EE, Lanske B, Erben RG. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. The Embo Journal. 33: 229-46. PMID 24434184 DOI: 10.1002/embj.201284188  0.56
2013 Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R, Mohammadi M, Andersson G, Lanske B, Larsson TE. Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. Plos Genetics. 9: e1003975. PMID 24348262 DOI: 10.1371/journal.pgen.1003975  0.84
2013 Huang Z, Chen H, Blais S, Neubert TA, Li X, Mohammadi M. Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation. Structure (London, England : 1993). 21: 1889-96. PMID 23972473 DOI: 10.1016/j.str.2013.07.017  0.84
2013 Chen H, Huang Z, Dutta K, Blais S, Neubert TA, Li X, Cowburn D, Traaseth NJ, Mohammadi M. Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations. Cell Reports. 4: 376-84. PMID 23871672 DOI: 10.1016/j.celrep.2013.06.025  0.84
2013 Uchihashi K, Nakatani T, Goetz R, Mohammadi M, He X, Razzaque MS. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. Contributions to Nephrology. 180: 124-37. PMID 23652555 DOI: 10.1159/000346792  0.84
2013 Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF, Seminara SB, ... ... Mohammadi M, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. American Journal of Human Genetics. 92: 725-43. PMID 23643382 DOI: 10.1016/j.ajhg.2013.04.008  0.84
2013 Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, Taylor RF, Mohammadi M, Canfield A, Kublickiene K, Larsson TE. Arterial klotho expression and FGF23 effects on vascular calcification and function. Plos One. 8: e60658. PMID 23577141 DOI: 10.1371/journal.pone.0060658  0.84
2013 Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nature Reviews. Molecular Cell Biology. 14: 166-80. PMID 23403721 DOI: 10.1038/nrm3528  0.56
2012 Goetz R, Ohnishi M, Kir S, Kurosu H, Wang L, Pastor J, Ma J, Gai W, Kuro-o M, Razzaque MS, Mohammadi M. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. The Journal of Biological Chemistry. 287: 29134-46. PMID 22733815 DOI: 10.1074/jbc.M112.342980  0.84
2012 Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway. Bone. 51: 621-8. PMID 22647968 DOI: 10.1016/j.bone.2012.05.015  0.56
2012 Goetz R, Ohnishi M, Ding X, Kurosu H, Wang L, Akiyoshi J, Ma J, Gai W, Sidis Y, Pitteloud N, Kuro-O M, Razzaque MS, Mohammadi M. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands. Molecular and Cellular Biology. 32: 1944-54. PMID 22451487 DOI: 10.1128/MCB.06603-11  0.84
2012 Beenken A, Mohammadi M. The structural biology of the FGF19 subfamily. Advances in Experimental Medicine and Biology. 728: 1-24. PMID 22396159 DOI: 10.1007/978-1-4614-0887-1_1  0.84
2012 Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V, Elting MW, Padidela R, Plummer L, Martin C, Feng B, ... ... Mohammadi M, et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. The Journal of Clinical Endocrinology and Metabolism. 97: E694-9. PMID 22319038 DOI: 10.1210/jc.2011-2938  0.84
2012 Wei W, Dutchak PA, Wang X, Ding X, Bookout AL, Goetz R, Mohammadi M, Gerard RD, Dechow PC, Mangelsdorf DJ, Kliewer SA, Wan Y. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ Proceedings of the National Academy of Sciences of the United States of America. 109: 3143-3148. PMID 22315431 DOI: 10.1073/pnas.1200797109  0.84
2012 Kalinina J, Dutta K, Ilghari D, Beenken A, Goetz R, Eliseenkova AV, Cowburn D, Mohammadi M. The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition. Structure (London, England : 1993). 20: 77-88. PMID 22244757 DOI: 10.1016/j.str.2011.10.022  0.84
2012 Beenken A, Eliseenkova AV, Ibrahimi OA, Olsen SK, Mohammadi M. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. The Journal of Biological Chemistry. 287: 3067-78. PMID 22057274 DOI: 10.1074/jbc.M111.275891  0.84
2011 Wang H, Venkatesh M, Li H, Goetz R, Mukherjee S, Biswas A, Zhu L, Kaubisch A, Wang L, Pullman J, Whitney K, Kuro-o M, Roig AI, Shay JW, Mohammadi M, et al. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. The Journal of Clinical Investigation. 121: 3220-32. PMID 21747170 DOI: 10.1172/JCI41514  0.84
2011 Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. American Journal of Physiology. Renal Physiology. 301: F371-7. PMID 21561999 DOI: 10.1152/ajprenal.00740.2010  0.56
2011 Beenken A, Mohammadi M. The molecular bases for FGF receptor activation in craniosynostosis and dwarfism syndromes Monographs in Human Genetics. 19: 45-57. DOI: 10.1159/000318837  0.84
2010 Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Molecular Endocrinology (Baltimore, Md.). 24: 2050-64. PMID 20667984 DOI: 10.1210/me.2010-0142  0.56
2010 Saxena K, Schieborr U, Anderka O, Duchardt-Ferner E, Elshorst B, Gande SL, Janzon J, Kudlinzki D, Sreeramulu S, Dreyer MK, Wendt KU, Herbert C, Duchaussoy P, Bianciotto M, Driguez PA, ... ... Mohammadi M, et al. Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex. The Journal of Biological Chemistry. 285: 26628-40. PMID 20547770 DOI: 10.1074/jbc.M109.095109  0.84
2010 Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, Costa EM, Mohammadi M, Pitteloud N, Mendonca BB, Latronico AC. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. The Journal of Clinical Endocrinology and Metabolism. 95: 3491-6. PMID 20463092 DOI: 10.1210/jc.2010-0176  0.84
2010 Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proceedings of the National Academy of Sciences of the United States of America. 107: 407-12. PMID 19966287 DOI: 10.1073/pnas.0902006107  0.84
2009 Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, ... ... Mohammadi M, et al. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism. Endocrine Reviews. 30: 934. PMID 28199515 DOI: 10.1210/edrv.30.7.9981  0.4
2009 Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, ... ... Mohammadi M, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism. 94: 4380-90. PMID 19820032 DOI: 10.1210/jc.2009-0179  0.84
2009 Makarenkova HP, Hoffman MP, Beenken A, Eliseenkova AV, Meech R, Tsau C, Patel VN, Lang RA, Mohammadi M. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Science Signaling. 2: ra55. PMID 19755711 DOI: 10.1126/scisignal.2000304  0.84
2009 Zhang F, Zhang Z, Lin X, Beenken A, Eliseenkova AV, Mohammadi M, Linhardt RJ. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry. 48: 8379-86. PMID 19591432 DOI: 10.1021/bi9006379  0.84
2009 Kalinina J, Byron SA, Makarenkova HP, Olsen SK, Eliseenkova AV, Larochelle WJ, Dhanabal M, Blais S, Ornitz DM, Day LA, Neubert TA, Pollock PM, Mohammadi M. Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Molecular and Cellular Biology. 29: 4663-78. PMID 19564416 DOI: 10.1128/MCB.01780-08  0.84
2009 Chen Y, Mohammadi M, Flanagan JG. Graded levels of FGF protein span the midbrain and can instruct graded induction and repression of neural mapping labels. Neuron. 62: 773-80. PMID 19555646 DOI: 10.1016/j.neuron.2009.05.023  0.84
2009 Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proceedings of the National Academy of Sciences of the United States of America. 106: 10853-8. PMID 19541642 DOI: 10.1073/pnas.0904187106  0.84
2009 Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. American Journal of Physiology. Renal Physiology. 297: F282-91. PMID 19515808 DOI: 10.1152/ajprenal.90742.2008  0.84
2009 Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, Tchetchik D, Eliseenkova AV, Xu CF, Neubert TA, Ornitz DM, Goldfarb M, Mohammadi M. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. The Journal of Biological Chemistry. 284: 17883-96. PMID 19406745 DOI: 10.1074/jbc.M109.001842  0.84
2009 Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature Reviews. Drug Discovery. 8: 235-53. PMID 19247306 DOI: 10.1038/nrd2792  0.84
2009 Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, ... ... Mohammadi M, et al. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research : McR. 7: 41-54. PMID 19147536 DOI: 10.1158/1541-7786.MCR-08-0021  0.84
2009 Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 433-41. PMID 18835926 DOI: 10.1096/fj.08-114397  0.84
2008 Chen H, Xu CF, Ma J, Eliseenkova AV, Li W, Pollock PM, Pitteloud N, Miller WT, Neubert TA, Mohammadi M. A crystallographic snapshot of tyrosine trans-phosphorylation in action. Proceedings of the National Academy of Sciences of the United States of America. 105: 19660-5. PMID 19060208 DOI: 10.1073/pnas.0807752105  0.84
2008 Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. The Journal of Cell Biology. 182: 459-65. PMID 18678710 DOI: 10.1083/jcb.200803024  0.84
2008 Falardeau J, Chung WCJ, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, ... ... Mohammadi M, et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice Journal of Clinical Investigation. 118: 2822-2831. PMID 18596921 DOI: 10.1172/JCI34538  0.84
2008 Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism. 8: 77-83. PMID 18585098 DOI: 10.1016/j.cmet.2008.05.006  0.56
2008 Abdel-Rahman WM, Kalinina J, Shoman S, Eissa S, Ollikainen M, Elomaa O, Eliseenkova AV, Bützow R, Mohammadi M, Peltomäki P. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin. Human Mutation. 29: 390-7. PMID 18165946 DOI: 10.1002/humu.20653  0.84
2007 Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. The parathyroid is a target organ for FGF23 in rats. The Journal of Clinical Investigation. 117: 4003-8. PMID 17992255 DOI: 10.1172/JCI32409  0.84
2007 Chen H, Ma J, Li W, Eliseenkova AV, Xu C, Neubert TA, Miller WT, Mohammadi M. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Molecular Cell. 27: 717-30. PMID 17803937 DOI: 10.1016/j.molcel.2007.06.028  0.76
2007 Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. The Journal of Clinical Investigation. 117: 2684-91. PMID 17710231 DOI: 10.1172/JCI31330  0.84
2007 Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. The Journal of Biological Chemistry. 282: 26687-95. PMID 17623664 DOI: 10.1074/jbc.M704165200  0.84
2007 Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metabolism. 5: 415-25. PMID 17550777 DOI: 10.1016/j.cmet.2007.05.003  0.84
2007 Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proceedings of the National Academy of Sciences of the United States of America. 104: 7432-7. PMID 17452648 DOI: 10.1073/pnas.0701600104  0.84
2007 Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, ... ... Mohammadi M, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology. 27: 3417-28. PMID 17339340 DOI: 10.1128/MCB.02249-06  0.84
2007 Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, ... ... Mohammadi M, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism Journal of Clinical Investigation. 117: 457-463. PMID 17235395 DOI: 10.1172/JCI29884  0.84
2006 Beenken A, Mohammadi M. Hedgehogs like it sweet, too. Proceedings of the National Academy of Sciences of the United States of America. 103: 17069-70. PMID 17088529 DOI: 10.1073/pnas.0608456103  0.84
2006 Pitteloud N, Meysing A, Quinton R, Acierno JS, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Molecular and Cellular Endocrinology. 254: 60-9. PMID 16764984 DOI: 10.1016/j.mce.2006.04.021  0.84
2006 Pitteloud N, Acierno JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6281-6. PMID 16606836 DOI: 10.1073/pnas.0600962103  0.84
2006 Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. The Journal of Biological Chemistry. 281: 15694-700. PMID 16597617 DOI: 10.1074/jbc.M601252200  0.84
2006 Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, Zhang F, Linhardt RJ, Joyner AL, Mohammadi M. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes & Development. 20: 185-98. PMID 16384934 DOI: 10.1101/gad.1365406  0.84
2006 Meyer RD, Mohammadi M, Rahimi N. A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1. The Journal of Biological Chemistry. 281: 867-75. PMID 16286478 DOI: 10.1074/jbc.M506454200  0.84
2005 Mohammadi M, Olsen SK, Goetz R. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Current Opinion in Structural Biology. 15: 506-16. PMID 16154740 DOI: 10.1016/j.sbi.2005.09.002  0.84
2005 Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology. 146: 4647-56. PMID 16081635 DOI: 10.1210/en.2005-0670  0.84
2005 Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine & Growth Factor Reviews. 16: 107-37. PMID 15863029 DOI: 10.1016/j.cytogfr.2005.01.008  0.84
2005 Xu CF, Lu Y, Ma J, Mohammadi M, Neubert TA. Identification of phosphopeptides by MALDI Q-TOF MS in positive and negative ion modes after methyl esterification. Molecular & Cellular Proteomics : McP. 4: 809-18. PMID 15753120 DOI: 10.1074/mcp.T400019-MCP200  0.4
2005 Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Molecular and Cellular Biology. 25: 671-84. PMID 15632068 DOI: 10.1128/MCB.25.2.671-684.2005  0.84
2005 Ibrahimi OA, Chiu ES, McCarthy JG, Mohammadi M. Understanding the molecular basis of Apert syndrome. Plastic and Reconstructive Surgery. 115: 264-70. PMID 15622262 DOI: 10.1097/01.PRS.0000146703.08958.95  0.84
2004 Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Human Molecular Genetics. 13: 2313-24. PMID 15282208 DOI: 10.1093/hmg/ddh235  0.84
2004 Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry. 43: 4724-30. PMID 15096041 DOI: 10.1021/bi0352320  0.84
2004 Olsen SK, Ibrahimi OA, Raucci A, Zhang F, Eliseenkova AV, Yayon A, Basilico C, Linhardt RJ, Schlessinger J, Mohammadi M. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proceedings of the National Academy of Sciences of the United States of America. 101: 935-40. PMID 14732692 DOI: 10.1073/pnas.0307287101  0.84
2004 Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Human Molecular Genetics. 13: 69-78. PMID 14613973 DOI: 10.1093/hmg/ddh011  0.84
2003 Sher I, Yeh BK, Mohammadi M, Adir N, Ron D. Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb. Febs Letters. 552: 150-4. PMID 14527678 DOI: 10.1016/S0014-5793(03)00909-8  0.84
2003 Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. The Journal of Biological Chemistry. 278: 34226-36. PMID 12815063 DOI: 10.1074/jbc.M303183200  0.84
2003 Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 100: 2266-71. PMID 12591959 DOI: 10.1073/pnas.0436500100  0.84
2002 Yeh BK, Eliseenkova AV, Plotnikov AN, Green D, Pinnell J, Polat T, Gritli-Linde A, Linhardt RJ, Mohammadi M. Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. Molecular and Cellular Biology. 22: 7184-92. PMID 12242295 DOI: 10.1128/MCB.22.20.7184-7192.2002  0.84
2001 Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proceedings of the National Academy of Sciences of the United States of America. 98: 7182-7. PMID 11390973 DOI: 10.1073/pnas.121183798  0.84
2001 Plotnikov AN, Eliseenkova AV, Ibrahimi OA, Shriver Z, Sasisekharan R, Lemmon MA, Mohammadi M. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. The Journal of Biological Chemistry. 276: 4322-9. PMID 11060292 DOI: 10.1074/jbc.M006502200  0.84
2000 Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Molecular Cell. 6: 743-50. PMID 11030354  0.84
Show low-probability matches.